This post conference report profiles various themes at the 57th Annual Meeting and Exposition of the American Society of Hematology (ASH), held December 5, 8, 2015, in Orlando, Florida, focusing on Immunologic Treatments because of the importance and popularity of immunotherapies for many different hematological cancers.
Results from pivotal trials presented at ASH
Highlights from other drugs and therapies of interest including
promising first-in human trials
Drugs whose topline results were presented at ASH
Listing of other data presentations supplied by BioMedTracker
(BMT) and changes to each drug’s likelihood of approval (LOA)
Supplemental material related to ASH
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: